Jihye Moon, PT, DPT | |
98-1005 Moanalua Rd Spc 410, Aiea, HI 96701-4702 | |
(808) 488-5555 | |
Not Available |
Full Name | Jihye Moon |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 98-1005 Moanalua Rd Spc 410, Aiea, Hawaii |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821762873 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | PT-5144 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jihye Moon, PT, DPT 98-1005 Moanalua Rd Spc 410, Aiea, HI 96701-4702 Ph: (808) 488-5555 | Jihye Moon, PT, DPT 98-1005 Moanalua Rd Spc 410, Aiea, HI 96701-4702 Ph: (808) 488-5555 |
News Archive
National HIV Testing Day is June 27, 2010. Like every day in a country where there are 56,000 new HIV infections a year, approximately 150 Americans will learn of their HIV infection on June 27th. So, here's the question - what happens on June 28th, the day after National HIV Testing Day? What do medical providers do with these newly-identified HIV patients?
The study found that when a development gene named Hoxb1 worked in a mouse's brain but not in the developing facial tissues, nerves extended outward from the brain but failed to reach the facial muscles, leaving the mouse unable to blink its eyes, flatten its ears or make other facial movements.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).
There is no single sexy chin. That's the conclusion of a new Dartmouth College global study of male and female preferences for facial characteristics of the opposite sex.
› Verified 8 days ago